Bausch Health Companies Inc. BHC
Set alert
At close
Pre-market · Nov 2, 8:25 AM ET
- YTD
- +17.99%
- 1 year
- +24.05%
- Open
- 8.93
- Prev close
- 8.91
- Mkt cap
- 3.07B
- Vol
- 8.64M
- Avg vol
- 3.36M
- EPS
- -2.26
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 8.18
- High
- 9.04
- Forward P/E
- 1.92
- Beta
- 0.37
- Short ratio
- 4.46
- Inst. own
- 65.21%
- Dividend
- 0.00
- Ex-div date
- Nov 9, 2010
- Earnings
- Feb 17, 2027
- 50-d avg
- 6.21
- 200-d avg
- 5.70
- 1y target
- 7.70
5D chart
Events in this range
- Oct 28, 2026Earnings: 1.77; estimate 1.25; surprise 41.6%
- Oct 29, 2026Rating: RBC Capital · Sector Perform → Sector Perform
- Oct 29, 2026Rating: Jefferies · Hold → Hold
Signals (95)
| Name | Time | Ago |
|---|---|---|
| RSI: Oversold | Oct 30, 3:50 PM | 2 days ago |
| RSI: Oversold | Oct 30, 3:35 PM | 2 days ago |
| RSI: Oversold | Oct 30, 3:00 PM | 2 days ago |
| RSI: Oversold | Oct 30, 2:40 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 2:20 PM | 2 days ago |
| SMA: Bearish | Oct 30, 2:10 PM | 2 days ago |
| SMA: Bearish | Oct 30, 2:10 PM | 2 days ago |
| SMA: Bullish | Oct 30, 1:55 PM | 2 days ago |
| SMA: Bearish | Oct 30, 1:45 PM | 2 days ago |
| SMA: Bullish | Oct 30, 1:35 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 1:20 PM | 2 days ago |
| SMA: Bearish | Oct 30, 12:30 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 12:30 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 12:25 PM | 2 days ago |
| SMA: Bullish | Oct 30, 12:15 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 11:40 AM | 2 days ago |
| SMA: Bearish | Oct 30, 11:20 AM | 2 days ago |
| SMA: Bullish | Oct 30, 11:05 AM | 2 days ago |
| MACD: Buy Signal | Oct 30, 10:55 AM | 2 days ago |
| SMA: Bullish | Oct 30, 10:45 AM | 2 days ago |
| SMA: Bearish | Oct 30, 9:40 AM | 2 days ago |
| SMA: Bearish | Oct 30, 9:40 AM | 2 days ago |
| SMA: Bullish | Oct 30, 9:35 AM | 2 days ago |
| SMA: Bullish | Oct 30, 9:35 AM | 2 days ago |
| SMA: Bearish | Oct 30, 9:30 AM | 3 days ago |
| SMA: Bullish | Oct 29, 3:55 PM | 3 days ago |
| SMA: Bearish | Oct 29, 3:50 PM | 3 days ago |
| SMA: Bearish | Oct 29, 3:50 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 3:45 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 3:40 PM | 3 days ago |
| SMA: Bullish | Oct 29, 3:30 PM | 3 days ago |
| SMA: Bullish | Oct 29, 3:25 PM | 3 days ago |
| SMA: Bearish | Oct 29, 3:15 PM | 3 days ago |
| RSI: Overbought | Oct 29, 2:10 PM | 3 days ago |
| SMA: Bullish | Oct 29, 12:15 PM | 3 days ago |
| SMA: Bearish | Oct 29, 12:05 PM | 3 days ago |
| RSI: Overbought | Oct 29, 11:45 AM | 3 days ago |
| SMA: Bullish | Oct 29, 11:40 AM | 3 days ago |
| SMA: Bearish | Oct 29, 11:00 AM | 3 days ago |
| MACD: Sell Signal | Oct 29, 10:40 AM | 3 days ago |
| RSI: Overbought | Oct 28, 3:55 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 3:50 PM | 4 days ago |
| SMA: Bullish | Oct 28, 3:40 PM | 4 days ago |
| SMA: Bearish | Oct 28, 3:35 PM | 4 days ago |
| SMA: Bullish | Oct 28, 3:30 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 3:10 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 2:40 PM | 4 days ago |
| SMA: Bullish | Oct 28, 2:05 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 1:30 PM | 4 days ago |
| RSI: Overbought | Oct 28, 1:05 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 12:55 PM | 4 days ago |
| SMA: Bullish | Oct 28, 12:25 PM | 4 days ago |
| SMA: Bullish | Oct 28, 12:25 PM | 4 days ago |
| SMA: Bearish | Oct 28, 12:20 PM | 4 days ago |
| SMA: Bullish | Oct 28, 11:00 AM | 4 days ago |
| MACD: Sell Signal | Oct 28, 10:30 AM | 4 days ago |
| RSI: Overbought | Oct 28, 9:30 AM | 5 days ago |
| SMA: Bullish | Oct 27, 3:45 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 3:45 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 3:40 PM | 5 days ago |
| SMA: Bearish | Oct 27, 3:35 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 3:05 PM | 5 days ago |
| SMA: Bearish | Oct 27, 2:25 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 2:25 PM | 5 days ago |
| SMA: Bullish | Oct 27, 2:00 PM | 5 days ago |
| SMA: Bearish | Oct 27, 1:55 PM | 5 days ago |
| SMA: Bullish | Oct 27, 1:35 PM | 5 days ago |
| SMA: Bearish | Oct 27, 1:30 PM | 5 days ago |
| SMA: Bullish | Oct 27, 1:25 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 1:05 PM | 5 days ago |
| RSI: Oversold | Oct 27, 12:45 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 11:55 AM | 5 days ago |
| SMA: Bearish | Oct 27, 11:45 AM | 5 days ago |
| SMA: Bullish | Oct 27, 11:35 AM | 5 days ago |
| MACD: Buy Signal | Oct 27, 11:35 AM | 5 days ago |
| MACD: Sell Signal | Oct 27, 11:25 AM | 5 days ago |
| MACD: Buy Signal | Oct 27, 11:20 AM | 5 days ago |
| MACD: Sell Signal | Oct 27, 11:15 AM | 5 days ago |
| MACD: Buy Signal | Oct 27, 10:35 AM | 5 days ago |
| MACD: Sell Signal | Oct 27, 10:20 AM | 5 days ago |
| MACD: Buy Signal | Oct 27, 10:10 AM | 5 days ago |
| MACD: Sell Signal | Oct 27, 9:45 AM | 5 days ago |
| SMA: Bearish | Oct 27, 9:30 AM | 6 days ago |
| SMA: Bearish | Oct 27, 9:30 AM | 6 days ago |
| MACD: Buy Signal | Oct 26, 3:30 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 2:50 PM | 6 days ago |
| SMA: Bearish | Oct 26, 2:45 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 2:40 PM | 6 days ago |
| SMA: Bullish | Oct 26, 2:35 PM | 6 days ago |
| SMA: Bearish | Oct 26, 12:30 PM | 6 days ago |
| SMA: Bullish | Oct 26, 12:20 PM | 6 days ago |
| SMA: Bearish | Oct 26, 12:10 PM | 6 days ago |
| SMA: Bullish | Oct 26, 12:05 PM | 6 days ago |
| SMA: Bearish | Oct 26, 11:35 AM | 6 days ago |
| SMA: Bearish | Oct 26, 10:55 AM | 6 days ago |
News
-
3 days ago benzinga.com
Jefferies Maintains Hold on Bausch Health Companies, Raises Price Target to $8
Jefferies analyst Young Li maintains Bausch Health Companies (NYSE:BHC) with a Hold and raises the price target from $6.5 to $8.
-
3 days ago benzinga.com
RBC Capital Maintains Sector Perform on Bausch Health Companies, Raises Price Target to $10
RBC Capital analyst Douglas Miehm maintains Bausch Health Companies (NYSE:BHC) with a Sector Perform and raises the price target from $9 to $10.
3 days ago benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Glaukos (NYSE:GKOS) shares rose 30.8% to $237.26 during Thursday's regular session. The company's market cap stands at $10.7 billion. The company's, Q3 earnings came out yesterday. Teladoc…
3 days ago zacks.com
BHC Q3 Earnings Beat on Salix Growth, Stock Gains 9% as Outlook Rises
Bausch Health shares jump 9% as Q3 earnings top estimates, driven by Xifaxan-led Salix growth, improved profitability and raised 2026 guidance.
3 days ago benzinga.com
Huntington Ingalls, Crocs, Carvana, Insmed And Other Big Stocks Moving Higher On Thursday
Stocks rallied on strong earnings and raised guidance, led by Huntington Ingalls, Porch, Teladoc and Crocs, despite the Dow falling 150 points.
4 days ago seekingalpha.com
Bausch Health Companies Inc. (BHC) Q3 2026 Earnings Call Transcript
Bausch Health Companies Inc. ( BHC ) Q3 2026 Earnings Call October 28, 2026 5:00 PM EDT Company Participants Garen Sarafian Thomas Appio - CEO & Director Jean-Jacques Charhon - Executive VP & CFO…
4 days ago zacks.com
Bausch (BHC) Reports Q3 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Bausch (BHC) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall…
4 days ago zacks.com
Bausch Health (BHC) Surpasses Q3 Earnings and Revenue Estimates
Bausch Health (BHC) came out with quarterly earnings of $1.77 per share, beating the Zacks Consensus Estimate of $1.08 per share. This compares to earnings of $1.16 per share a year ago.
4 days ago marketbeat.com
What Bausch Health Cos (BHC) Said on Its Q3 Earnings Call
Bausch Health Cos NYSE: BHC raised its full-year 2026 outlook for the second consecutive quarter after reporting third-quarter growth across its operating segments, led by Salix and supported by…
4 days ago benzinga.com
Bausch Health Companies Q3 2026 Earnings Call Transcript
Bausch Health Companies (NYSE:BHC) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is…
-
4 days ago benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Lakewood-Amedex (NASDAQ:LABT) stock rose 20.4% to $0.34 during Wednesday's after-market session. Glaukos (NYSE:GKOS) stock rose 16.85% to $212.01. The company's market cap stands at $10.6…
-
4 days ago benzinga.com
Bausch Health Companies Announces $50M Buyback Plan
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced that its Board of Directors has authorized a share repurchase program under which the Company may repurchase its common shares…
4 days ago prnewswire.com
Bausch Health Announces Full Redemption of 8.500% Senior Notes Due 2027
LAVAL, QC, Oct. 28, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced that its subsidiary, Bausch Health Americas, Inc., will issue an irrevocable notice of…
4 days ago prnewswire.com
Bausch Health Announces US$50 Million Share Repurchase Program
LAVAL, QC, Oct. 28, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced that its Board of Directors has authorized a share repurchase program under which the Company…
-
4 days ago benzinga.com
Bausch Health Companies Raises FY2026 Sales Guidance from $10.790B-$11.040B to $10.975B-$11.175B vs $10.927B Est
Bausch Health Companies (NYSE:BHC) raises FY2026 sales outlook from $10.790 billion-$11.040 billion to $10.975 billion-$11.175 billion vs $10.927 billion estimate.
-
4 days ago benzinga.com
Bausch Health Companies Q3 Adj. EPS $1.77 Beats $1.29 Estimate, Sales $2.941B Beat $2.757B Estimate
Bausch Health Companies (NYSE:BHC) reported quarterly earnings of $1.77 per share which beat the analyst consensus estimate of $1.29 by 37.21 percent. This is a 52.59 percent increase over earnings…
4 days ago prnewswire.com
BAUSCH HEALTH ANNOUNCES THIRD QUARTER 2026 RESULTS, RAISES GUIDANCE
Third Quarter Consolidated Revenues of $2.94 billion, up 10% on a Reported basis and 8% on an Organic1 basis over the prior year period GAAP Net Income Attributable to Bausch Health of $436 million…
6 days ago zacks.com
BHC Q3 Earnings Preview: Here's What You Should Know
Bausch Health reports Q3 2026 results on Oct. 28, with $2.75 billion in expected sales. Explore key segment drivers and mixed earnings surprise history.
1 week ago defenseworld.net
Analyzing Bausch Health Cos (NYSE:BHC) & Recordati Industria Chimica E Farmaceutica (OTCMKTS:RCDTF)
Bausch Health Cos (NYSE: BHC - Get Free Report) and Recordati Industria Chimica E Farmaceutica (OTCMKTS:RCDTF - Get Free Report) are both healthcare companies, but which is the superior investment?…
-
2 weeks ago benzinga.com
Bausch Health Canada Announces Expanded Public Reimbursement For PrOKEDI 75 Mg And 100 Mg, With Coverage Now Available In Seven Provinces And Multiple Federal Drug Plans
PrOKEDI® is now listed in Ontario, Quebec, British Columbia, Alberta, Saskatchewan, Nova Scotia and Prince Edward Island, as well as through federal drug plans administered by the Non-Insured Health…
2 weeks ago defenseworld.net
Bausch Health Cos Inc. (NYSE:BHC) Stock Has Consensus Target Price of $8.00
Shares of Bausch Health Cos Inc. (NYSE: BHC - Get Free Report) have received a consensus rating of "Hold" from the seven brokerages that are covering the firm, Marketbeat.com reports. One research…
2 weeks ago benzinga.com
Why Is Bausch + Lomb Stock Falling Monday?
Bausch + Lomb stock drops 10% following sudden CEO departure, despite raising full-year 2026 EBITDA guidance.
2 weeks ago defenseworld.net
Bausch Health Cos (NYSE:BHC) Shares Gap Up – What’s Next?
Bausch Health Cos Inc. (NYSE: BHC - Get Free Report)'s stock price gapped up prior to trading on Monday. The stock had previously closed at $6.04, but opened at $6.27. Bausch Health Cos shares last…
3 weeks ago prnewswire.com
Six-Month Pilot Study Demonstrates Improved Guideline Adherence Following Implementation of Standardized Cirrhosis Clinical Pathway
LAVAL, QC, Oct. 12, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals ("Salix"), announced results from a multicenter…
-
3 weeks ago benzinga.com
Bausch + Lomb Appoints Chairman Thomas J. Appio As Interim CEO, Effective Immediately; Company And Its Parent Bausch Health Expect To Raise FY26 Adjusted EBITDA Guidance, Excluding Acquired IPR&D
Preliminary Update on 2026 Guidance2Based on preliminary third-quarter results, Bausch + Lomb and Bausch Health currently expect to raise full-year 2026 adjusted EBITDA excluding Acquired IPR&D1…
3 weeks ago businesswire.com
Bausch + Lomb and Bausch Health Announce Appointment of Thomas J. Appio as Interim Bausch + Lomb CEO, Expect to Raise Full-Year 2026 Guidance
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company, and its parent company, Bausch Health Companies Inc. (NYSE/TSX: BHC), today…
3 weeks ago prnewswire.com
Bausch Health to Announce Third Quarter 2026 Results on October 28, 2026
LAVAL, QC, Oct. 6, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release third quarter 2026 financial results after market close on Wednesday, October 28, 2026. Bausch…
1 month ago zacks.com
4 Low-Beta Healthcare Stocks to Buy Amid Fears of Another Rate Hike
ABT, CORT, PGEN and BHC offer low-beta healthcare exposure as rate-hike fears and market volatility persist.
1 month ago zacks.com
Consumer Confidence Falls Amid Ongoing Geopolitical Tensions: 4 Picks
BHC, CDNA, DOLE and CHEF offer defensive exposure as consumer confidence falls amid inflation and geopolitical tensions.
1 month ago defenseworld.net
Head-To-Head Contrast: Bristol Myers Squibb (NYSE:BMY) vs. Bausch Health Cos (NYSE:BHC)
Bristol Myers Squibb (NYSE: BMY - Get Free Report) and Bausch Health Cos (NYSE: BHC - Get Free Report) are both healthcare companies, but which is the better investment? We will contrast the two…
1 month ago zacks.com
Best Value Stocks to Buy for September 22nd
BHC, OPHC and TRVG made it to the Zacks Rank #1 (Strong Buy) value stocks list on September 22nd, 2026.
1 month ago defenseworld.net
Bausch Health Cos Inc. (NYSE:BHC) Receives $8.00 Consensus Target Price from Brokerages
Bausch Health Cos Inc. (NYSE: BHC - Get Free Report) has been given a consensus rating of "Reduce" by the seven brokerages that are presently covering the company, MarketBeat Ratings reports. One…
1 month ago benzinga.com
Why Tempest Therapeutics Shares Are Trading Higher By Around 50%; Here Are 20 Stocks Moving Premarket
Tempest shares surged 49.6% on a Senlang CD7 CAR-T option deal, while several small-cap stocks posted sharp premarket gains and losses.
2 months ago benzinga.com
This Hedge Fund Portfolio Shrinks 17% as Billionaire Bets Big on Gold
Paulson's hedge fund reduced its equity book to $2.58B in Q2, exiting two positions and opening a stake in Alphabet.
3 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Nuwellis (NASDAQ:NUWE) stock moved upwards by 123.7% to $4.23 during Thursday's regular session. GlucoTrack (NASDAQ:GCTK) shares moved upwards by 79.85% to $0.51. The company's market cap…
-
3 months ago benzinga.com
Bausch Health Companies Raises FY2026 Sales Guidance from $10.670B-$10.920B to $10.790B-$11.040B vs $10.773B Est
Bausch Health Companies (TSX:BHC) raises FY2026 sales outlook from $10.670 billion-$10.920 billion to $10.790 billion-$11.040 billion vs $10.773 billion estimate.
-
3 months ago benzinga.com
Bausch Health Companies Q2 Adj. EPS $1.26 Beats $1.06 Estimate, Sales $2.852B Beat $2.679B Estimate
Bausch Health Companies (TSX:BHC) reported quarterly earnings of $1.26 per share which beat the analyst consensus estimate of $1.06 by 17.76 percent. This is a 38.46 percent increase over earnings of…
-
3 months ago benzinga.com
Bausch Health Announces Quebec Provincial Listing Of Prokedi For Treatment Of Schizophrenia In Adults
PrOKEDI® is a prolonged-release injectable suspension of risperidone indicated for the treatment of schizophrenia in adults. According to the Canadian product monograph, PrOKEDI® achieves clinically…
-
4 months ago benzinga.com
Bausch Health, Canada, Completes Negotiations With pan-Canadian Pharmaceutical Alliance Resulting In LOI For PrOKEDI 75mg And 100mg, Long-Acting Injectable Antipsychotic Agent For Schizophrenia Treatment
Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced that it has successfully completed negotiations with the pan-Canadian Pharmaceutical Alliance…
-
5 months ago benzinga.com
Bausch Health And Solta Medical Announce Thermage Awarded AAA Well-Known Trademark Certification By China Trademark Association
Thermage®, a pioneer in non-invasive skin tightening, was awarded the AAA Well-Known Trademark Certification, the highest recognition in China's domestic trademark evaluation system.LAVAL, QC, May…
-
6 months ago benzinga.com
Bausch Health Companies Raises FY2026 Sales Guidance from $10.625B-$10.875B to $10.670B-$10.920B vs $10.595B Est
Bausch Health Companies (NYSE:BHC) raises FY2026 sales outlook from $10.625 billion-$10.875 billion to $10.670 billion-$10.920 billion vs $10.595 billion estimate.
-
6 months ago benzinga.com
Bausch Health Companies Q1 Adj. EPS $0.78 Beats $0.69 Estimate, Sales $2.524B Beat $2.409B Estimate
Bausch Health Companies (NYSE:BHC) reported quarterly earnings of $0.78 per share which beat the analyst consensus estimate of $0.69 by 13.04 percent. This is a 27.87 percent increase over earnings…
6 months ago benzinga.com
Earnings Scheduled For April 29, 2026
Earnings Scheduled For April 29, 2026
-
6 months ago benzinga.com
RBC Capital Maintains Sector Perform on Bausch Health Companies, Lowers Price Target to $9
RBC Capital analyst Douglas Miehm maintains Bausch Health Companies (NYSE:BHC) with a Sector Perform and lowers the price target from $10 to $9.
-
8 months ago benzinga.com
Barclays Maintains Equal-Weight on Bausch Health Companies, Lowers Price Target to $7
Barclays analyst Glen Santangelo maintains Bausch Health Companies (NYSE:BHC) with a Equal-Weight and lowers the price target from $8 to $7.
-
8 months ago benzinga.com
Bausch Health Companies Sees FY2026 Sales $10.625B-$10.875B vs $10.595B Est
Bausch Health Companies (NYSE:BHC) sees FY2026 sales of $10.625 billion-$10.875 billion vs $10.595 billion analyst estimate.
8 months ago benzinga.com
Insights into Bausch Health Companies Q4 Earnings
Insights into Bausch Health Companies Q4 Earnings
8 months ago benzinga.com
Bausch Health Companies Q4 Earnings Report: What Investors Need to Know
Bausch Health Companies Q4 Earnings Report: What Investors Need to Know
-
8 months ago benzinga.com
Bausch Health Companies Q4 Adj. EPS $1.10 Misses $1.26 Estimate, Sales $2.796B Beat $2.696B Estimate
Bausch Health Companies (NYSE:BHC) reported quarterly earnings of $1.10 per share which missed the analyst consensus estimate of $1.26 by 12.97 percent. This is a 5.98 percent decrease over earnings…
-
8 months ago benzinga.com
Earnings Scheduled For February 18, 2026
Earnings Scheduled For February 18, 2026